Skip to content

Alcon

US · ALC #656 by market cap Listed 1970
74.31 -0.19 -0.26%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Alcon

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Founded
1945
CEO
Mr. David J. Endicott
Employees
25,942
Headquarters
Geneva, Geneve (Geneva), Switzerland
Fiscal year end
12-31
Website
alcon.com

Company profile

Exchange
US
Symbol
ALC
Market-cap rank
#656
Listing date
1970-01-01
Market cap
35.92B
Float cap
35.83B
Shares out
483.40M
Float shares
482.15M

Sectors & themes

Medical Instruments & Supplies Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:40 · For reference only, not investment advice and not tailored to your situation.

Alcon discussion 0 comments

Add a comment